JY
IGC icon

Jeff Yass’s IGC Pharma IGC Stock Holding History

Jeff Yass’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,600
Closed -$2.97K – 12691
2023
Q4 		$2.97K Sell
10,600
-6,200
-37% -$1.92K ﹤0.01% 12154
2023
Q3 		$6.05K Buy
16,800
+800
+5% +$286 ﹤0.01% 11765
2023
Q2 		$4.96K Hold
16,000
– – ﹤0.01% 11831
2023
Q1 		$5.44K Sell
16,000
-1,200
-7% -$450 ﹤0.01% 12299
2022
Q4 		$5.5K Sell
17,200
-37,800
-69% -$15.4K ﹤0.01% 12027
2022
Q3 		$24K Buy
55,000
+1,000
+2% +$533 ﹤0.01% 12529
2022
Q2 		$29K Sell
54,000
-1,400
-3% -$883 ﹤0.01% 12235
2022
Q1 		$53K Sell
55,400
-56,300
-50% -$54.7K ﹤0.01% 12285
2021
Q4 		$109K Sell
111,700
-99,700
-47% -$134K ﹤0.01% 12081
2021
Q3 		$313K Buy
211,400
+48,900
+30% +$79.1K ﹤0.01% 10507
2021
Q2 		$267K Sell
162,500
-185,000
-53% -$282K ﹤0.01% 11026
2021
Q1 		$622K Buy
347,500
+174,100
+100% +$316K ﹤0.01% 8960
2020
Q4 		$271K Buy
173,400
+47,000
+37% +$69.5K ﹤0.01% 9472
2020
Q3 		$131K Buy
+126,400
New +$128K ﹤0.01% 9772
2019
Q4 		– Sell
-22,400
Closed -$22K – 10117
2019
Q3 		$22K Buy
22,400
+8,200
+58% +$9.87K ﹤0.01% 9938
2019
Q2 		$23K Sell
14,200
-7,800
-35% -$11K ﹤0.01% 9990
2019
Q1 		$46K Buy
+22,000
New +$50K ﹤0.01% 8479

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM

Jeff Yass's IGC Position: Q2 2026 in Review

Jeff Yass reduced its IGC Pharma (IGC) stake by 76% in Q2 2026, selling an estimated $27.7K and leaving 28,882 shares worth $7.86K. The position accounts for ﹤0.01% of the portfolio, ranked #13162.

Jeff Yass first reported a position in IGC in Q1 2016 and has held it in 27 quarters since. The position peaked at $878K in Q1 2021. 36 funds tracked by Wall St. Rank hold IGC as of Q2 2026.

  • Jeff Yass held 28,882 shares of IGC Pharma worth $7.86K as of Q2 2026.
  • Jeff Yass sold 93,713 IGC Pharma shares in Q2 2026, an estimated $27.7K.
  • IGC Pharma made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13162 holding.
  • Jeff Yass first reported a position in IGC Pharma in Q1 2016 and has held it in 27 quarters since.
  • Jeff Yass's IGC Pharma position peaked at $878K in Q1 2021.
  • 36 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.